HK Stock MarketDetailed Quotes
09886 DINGDANG HEALTH
- 0.530
- +0.010+1.92%
Market Closed Sep 27 16:08 CST
710.98MMarket Cap-3271P/E (TTM)
0.580High0.495Low10.21MVolume0.530Open0.520Pre Close5.57MTurnover0.76%Turnover RatioLossP/E (Static)1.34BShares2.50052wk High0.33P/B710.98MFloat Cap0.41052wk Low--Dividend TTM1.34BShs Float20.200Historical High--Dividend LFY16.35%Amplitude0.410Historical Low0.545Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
DINGDANG HEALTH Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.92%2.27B | 12.19%4.86B | 12.94%2.25B | 17.68%4.33B | --1.99B | 26.64%987.41M | 65.07%3.68B | 55.90%779.71M | 74.71%2.23B | --500.12M |
| Operating income | 0.92%2.27B | 12.19%4.86B | 12.94%2.25B | 17.68%4.33B | 1.99B | 26.64%987.41M | 65.07%3.68B | 55.90%779.71M | 74.71%2.23B | 500.12M |
| Cost of sales | 3.08%-1.52B | -16.21%-3.35B | -18.06%-1.56B | -14.43%-2.88B | ---1.33B | -20.30%-652.99M | -72.08%-2.52B | -68.40%-542.79M | -81.52%-1.46B | ---322.31M |
| Operating expenses | 3.08%-1.52B | -16.21%-3.35B | -18.06%-1.56B | -14.43%-2.88B | -1.33B | -20.30%-652.99M | -72.08%-2.52B | -68.40%-542.79M | -81.52%-1.46B | -322.31M |
| Gross profit | 10.08%751.74M | 4.21%1.51B | 2.74%682.91M | 24.72%1.45B | 664.67M | 41.15%334.42M | 51.70%1.16B | 33.24%236.92M | 63.04%766.19M | 177.81M |
| Selling expenses | -4.45%-485.87M | -7.10%-972.71M | -10.78%-465.16M | -8.80%-908.24M | ---419.91M | -31.24%-208.77M | -89.16%-834.78M | -79.67%-159.08M | -58.48%-441.31M | ---88.54M |
| Administrative expenses | 1.31%-126.09M | 22.68%-258.66M | 38.14%-127.76M | 30.49%-334.52M | ---206.52M | -158.10%-100.69M | -297.84%-481.26M | -112.25%-39.01M | -108.93%-120.97M | ---18.38M |
| Research and development expenses | 20.60%-24.36M | 26.95%-64.98M | 33.56%-30.68M | 7.50%-88.95M | ---46.17M | -16.13%-22.64M | -17.17%-96.16M | -19.20%-19.5M | -56.73%-82.07M | ---16.36M |
| Revaluation surplus | ---- | ---- | ---- | -174.56%-2.5B | ---362.46M | 58.08%-280.62M | -20.89%-912.2M | -2,536.20%-669.36M | -400.77%-754.59M | ---25.39M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | -174.56%-2.5B | ---362.46M | 58.08%-280.62M | -20.89%-912.2M | -2,536.20%-669.36M | -400.77%-754.59M | ---25.39M |
| Impairment and provision | -331.47%-2.2M | 76.97%-356K | 276.58%950K | -483.40%-1.55M | ---538K | -87.56%-1.12M | 91.60%-265K | ---595K | -1,326.70%-3.15M | ---- |
| -Other impairment is provision | -331.47%-2.2M | 76.97%-356K | 276.58%950K | -483.40%-1.55M | ---538K | -87.56%-1.12M | 91.60%-265K | ---595K | -1,326.70%-3.15M | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---3.84M | 4.31%-1.95M | -193.28%-17.78M | -0.25%-2.04M | -8.80%-6.06M | ---2.04M |
| Special items of operating profit | -12.74%-191.36M | 2.58%-424.86M | 17.91%-169.73M | -18.46%-436.1M | ---206.75M | -28.19%-109.33M | -45.65%-368.13M | -58.08%-85.29M | -32.93%-252.75M | ---53.95M |
| Operating profit | 28.62%-78.14M | 92.53%-210.9M | 81.18%-109.47M | -82.41%-2.82B | -581.52M | 47.06%-390.69M | -73.05%-1.55B | -2,649.51%-737.94M | -237.14%-894.71M | -26.84M |
| Financing cost | -10.77%-4.35M | 0.49%-7.88M | ---3.93M | ---7.92M | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | -402.99%-1.18M | ---2.45M | ---234K | ---- | ---- | ---- | ---- | ---- | -181.32%-256K | ---64K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | -57.01%-11.4M | -467.22%-33.6M | -1,471.00%-7.26M | -2,580.54%-5.92M | ---462K |
| Earning before tax | 26.37%-83.66M | 92.19%-221.23M | 80.46%-113.63M | -79.04%-2.83B | -581.52M | 46.04%-402.09M | -75.59%-1.58B | -2,623.18%-745.2M | -239.07%-900.89M | -27.37M |
| Tax | -65.02%-6.14M | 4.81%-9.64M | 15.36%-3.72M | 40.82%-10.13M | ---4.39M | 37.34%-2.33M | 8.93%-17.12M | 33.66%-3.72M | -128.18%-18.79M | ---5.6M |
| After-tax profit from continuing operations | 23.48%-89.8M | 91.88%-230.87M | 79.97%-117.35M | -77.76%-2.84B | -585.91M | 46.00%-404.42M | -73.86%-1.6B | -2,171.65%-748.92M | -235.73%-919.68M | -32.97M |
| Earning after tax | 23.48%-89.8M | 91.88%-230.87M | 79.97%-117.35M | -77.76%-2.84B | -585.91M | 46.00%-404.42M | -73.86%-1.6B | -2,171.65%-748.92M | -235.73%-919.68M | -32.97M |
| Minority profit | -11.16%-5.31M | 43.03%-5.06M | 39.10%-4.78M | 57.61%-8.88M | ---7.84M | -23.20%-5.55M | -558.38%-20.95M | -254.33%-4.51M | 69.07%4.57M | --2.92M |
| Profit attributable to shareholders | 24.95%-84.49M | 92.03%-225.81M | 80.53%-112.57M | -79.55%-2.83B | -578.07M | 46.42%-398.86M | -70.74%-1.58B | -1,974.20%-744.41M | -234.10%-924.25M | -35.89M |
| Basic earnings per share | 25.00%-0.06 | 94.96%-0.17 | 91.30%-0.08 | -1.81%-3.37 | -0.92 | 78.42%-0.63 | 8.56%-3.31 | -2.92 | -235.19%-3.62 | |
| Diluted earnings per share | 25.00%-0.06 | 94.96%-0.17 | 91.30%-0.08 | -1.81%-3.37 | -0.92 | 78.42%-0.63 | 8.56%-3.31 | -2.92 | -235.19%-3.62 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data